Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Role of a Combination of Nutraceuticals in the Control of Cardiovascular Risk (ARMOPREVCVR)

This study has been completed.
Information provided by (Responsible Party):
Bruno Trimarco, Federico II University Identifier:
First received: February 9, 2011
Last updated: February 2, 2016
Last verified: February 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2014
  Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)